FL: Tafasitamab Plus Combo Boosts Outcomes

Combination of anti-CD19 and CD20 monoclonal antibodies could represent “new standard of care” in follicular lymphoma.
Medscape Medical News

source https://www.medscape.com/viewarticle/fl-tafasitamab-plus-combo-boosts-outcomes-2024a1000neu?src=rss